FSSAI Issues Notices to Companies Over Misleading Protein Supplement Claims
The Food Safety and Standards Authority of India (FSSAI) has issued notices to Dr Reddy's, Nestle Health Science, Tirupati Wellness, Amazon, Flipkart, and Netmeds over allegedly misleading health claims related to protein support, muscle strength, immunity, and energy metabolism. The notices focus on the product Celevida GLP, which was promoted with claims linking it to GLP-1 GIP therapies for weight loss. FSSAI has asked these companies to explain why regulatory action should not be taken, citing concerns that the claims and branding could mislead consumers about the products' health benefits.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 62/100.
Outlets measured: economictimes, mint, moneycontrol, businessstandard, firstpost, deccanherald, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (48–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 8 Oct, 04:04 pm. Other outlets followed.